EORTC QLQ-C30 normative data for the United Kingdom: Results of a cross-sectional survey of the general population

被引:2
|
作者
Young, Teresa [1 ]
Velikova, Galina [2 ]
Liegl, Gregor [3 ,4 ,5 ,6 ]
Rose, Matthias [3 ,4 ,5 ,6 ,7 ]
Nolte, Sandra [3 ,4 ,5 ,6 ,8 ,9 ]
机构
[1] East & North Hertfordshire NHS Trust including Mt, Northwood HA6 2RN, Middx, England
[2] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Med Res St Jamess, Leeds, England
[3] Charite Univ Med Berlin, Ctr Patient Ctr Outcomes Res, Berlin, Germany
[4] Free Univ Berlin, Berlin, Germany
[5] Humboldt Univ, Berlin, Germany
[6] Charite Univ Med Berlin, Dept Neuroradiol, Berlin, Germany
[7] Univ Med Berlin, German Ctr Mental Hlth DZPG, Berlin, Germany
[8] Univ Melbourne, Ctr Hlth Policy, Melbourne Hlth Econ, Melbourne, Vic, Australia
[9] Swinburne Univ Technol, Sch Hlth Sci, Melbourne, Vic, Australia
关键词
Quality of life; Patient reported outcome measures; Normative data; Reference values; United Kingdom; Cancer; QUALITY-OF-LIFE; CLINICAL-TRIALS; HEALTH; OUTCOMES;
D O I
10.1016/j.ejca.2024.113927
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The cancer -specific health -related quality of life (HRQoL) questionnaire of the European Organisation for Research and Treatment of Cancer (EORTC), the EORTC QLQ-C30, is a frequently applied questionnaire to assess cancer patients ' self -reported health used as part of research and clinical practice. Normative data obtained from the general population can facilitate the interpretation of these data. Despite its frequent application, no detailed EORTC QLQ-C30 normative data have yet been published for the United Kingdom (UK). This study presents detailed EORTC QLQ-C30 normative data for the United Kingdom overall and by sex and age. Methods: The data are drawn from a larger published, international, cross-sectional online survey. For the recruitment, the sample was stratified by sex (males, females) and age in five age groups with a sample size of n = 100 per subgroup. Results: A total of N = 1026 UK respondents completed the survey (n = 517 females, n = 509 males). There were no clear subgroup patterns by sex or age; however, older patients tended to show higher (i.e., better) scores in emotional and social functioning; they also reported some of the lowest (i.e., best) scores for symptoms, such as insomnia, appetite loss, diarrhoea, nausea/vomiting or financial difficulties. Conclusion: This paper provides EORTC QLQ-C30 general population normative data for the UK, further stratified by sex and age. These data will greatly support the interpretation of EORTC QLQ-C30 scale scores obtained from UK cancer patients, and also enable comparison with other detailed national normative datasets collected in the same project, across several other European countries and the US.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity
    Therese Juul
    Morten Aagaard Petersen
    Bernhard Holzner
    Søren Laurberg
    Peter Christensen
    Mogens Grønvold
    Quality of Life Research, 2014, 23 : 2183 - 2193
  • [22] A cross-validation of the European organization for research and treatment of cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer
    Kobayashi, K
    Takeda, F
    Teramukai, S
    Gotoh, I
    Sakai, H
    Yoneda, S
    Noguchi, Y
    Ogasawara, H
    Yoshida, K
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (06) : 810 - 815
  • [23] Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity
    Juul, Therese
    Petersen, Morten Aagaard
    Holzner, Bernhard
    Laurberg, Soren
    Christensen, Peter
    Gronvold, Mogens
    QUALITY OF LIFE RESEARCH, 2014, 23 (08) : 2183 - 2193
  • [24] European reference values for the quality of life questionnaire EORTC QLQ-C30: Results of a German investigation and a summarizing analysis of six European general population normative studies
    Hinz, Andreas
    Singer, Susanne
    Braehler, Elmar
    ACTA ONCOLOGICA, 2014, 53 (07) : 958 - 965
  • [25] Which EORTC QLQ-C30 and-CR29 scores are relevant for clinicians for therapy planning and decisions? Results of an online survey
    Sibert, Nora Tabea
    Breidenbach, Clara
    Wesselmann, Simone
    Schult, Sarah
    Benz, Stefan Rolf
    Post, Stefan
    Seufferlein, Thomas
    Schloss, Patrick
    Kowalski, Christoph
    COLOPROCTOLOGY, 2021, 43 (06) : 411 - 416
  • [26] Reference data of the EORTC QLQ-C30 questionnaire: five consecutive annual assessments of approximately 2000 representative Dutch men and women
    Mols, Floortje
    Husson, Olga
    Oudejans, Marije
    Vlooswijk, Carla
    Horevoorts, Nicole
    van de Poll-Franse, Lonneke V.
    ACTA ONCOLOGICA, 2018, 57 (10) : 1381 - 1391
  • [27] Health-related quality of life assessed by the EORTC QLQ-C30 questionnaire in the general Slovenian population
    Velenik, Vaneja
    Secerov-Ermenc, Ajra
    But-Hadzic, Jasna
    Zadnik, Vesna
    RADIOLOGY AND ONCOLOGY, 2017, 51 (03) : 342 - 350
  • [28] Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - General approach and initial results for physical functioning
    Petersen, Morten Aa.
    Groenvold, Mogens
    Aaronson, Neil K.
    Chie, Wei-Chu
    Conroy, Thierry
    Costantini, Anna
    Fayers, Peter
    Helbostad, Jorunn
    Holzner, Bernhard
    Kaasa, Stein
    Singer, Susanne
    Velikova, Galina
    Young, Teresa
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (08) : 1352 - 1358
  • [29] The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry
    Husson, Olga
    de Rooij, Belle H.
    Kieffer, Jacobien
    Oerlemans, Simone
    Mols, Floortje
    Aaronson, Neil K.
    Graaf, Winette T. A.
    van de Poll-Franse, Lonneke V.
    ONCOLOGIST, 2020, 25 (04) : E722 - E732
  • [30] Reference values for the EORTC QLQ-C30 quality of life questionnaire in a random sample of the Swedish population
    Derogar, Maryam
    van der Schaaf, Maartje
    Lagergren, Pernilla
    ACTA ONCOLOGICA, 2012, 51 (01) : 10 - 16